Місце в контексті: Teva Advances Vitiligo Antibody to Phase 2b After Results · Держава Ізраїль

1 лип.

5,000 Doctors Oppose Israel Medical Boycott Push

2 лип.

Health Ministry Reports Hospital Infection Decline

Вибрана новина7 лип.

Teva Advances Vitiligo Antibody to Phase 2b After Results

3 лип.

Israeli Vets Warn Animal-Eye Superbugs Can Spread to Humans

3 лип.

TAU Study Shows Tumors Reprogram Immune Cells